• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

短期 2 型糖尿病患者的尿肾小管标志物:一项横断面研究。

Urinary tubular biomarkers in short-term type 2 diabetes mellitus patients: a cross-sectional study.

机构信息

Department of Laboratory, Affiliated Houjie Hospital, Guangdong Medical College, Dongguan, 523945, Guangdong, China.

出版信息

Endocrine. 2012 Feb;41(1):82-8. doi: 10.1007/s12020-011-9509-7. Epub 2011 Jul 21.

DOI:10.1007/s12020-011-9509-7
PMID:21779943
Abstract

The purpose of this study was to investigate the prevalence of tubular damage in short-term (less than five years) type 2 diabetes mellitus (T2DM) patients and to explore the correlation between tubular markers and their relationship with renal indices at different stages of diabetic nephropathy. A group of 101 short-term T2DM patients and 28 control subjects were recruited. Tubular markers, such as neutrophil gelatinase-associated lipocalin (NGAL), N-acetyl-β-D: -glucosaminidase (NAG), and kidney injury molecule 1 (KIM-1), as well as urinary albumin excretion were measured in voided urine. Glomerular filtration rate (GFR) was estimated via Macisaac's formula. The patients were further categorized into three groups, namely, the normoalbuminuria, microalbuminuria, and macroalbuminuria groups, according to their urine albumin/creatinine ratio (UACR). Urinary tubular markers were compared and their correlations with renal indices [UACR and estimated GFR (eGFR)] were analyzed among the different diabetic groups. Compared with the control group, Urinary NGAL [median (IQR)][83.6(41.4-138.7) μg/gcr vs. 32.9(26.1-64.5) μg/gcr], NAG [13.5(8.7-17.9) U/gcr vs. 7.6(6.5-13.0) U/gcr] and KIM-1 [120.0(98.4-139.9) ng/gcr vs. 103.1(86.8-106.2) ng/gcr] in the T2DM were all markedly increased. For all patients, urinary NGAL had stronger positive correlations with UACR than NAG (R = 0.556 vs. 0.305, both P < 0.05). In addition, only urinary NGAL showed a negative correlation with eGFR (R = -0.215, P < 0.05). Urinary KIM-1, however, showed no significant difference among the three T2DM groups and did not correlate with either UACR or eGFR. As UACR increased from the normoalbuminuria to the last macroalbuminuria group, all of the markers increased. However, only the concentrations of NGAL were statistically different among the three diabetic groups. The correlation between the tubular markers and their relationships with the renal indices differed markedly among the three T2DM groups. In conclusion, these results suggest that tubular damage is common in short-term T2DM patients. Urinary NGAL may be a promising early marker for monitoring renal impairment in short-term T2DM patients.

摘要

本研究旨在探讨短期(<5 年)2 型糖尿病(T2DM)患者肾小管损伤的患病率,并探讨肾小管标志物与不同糖尿病肾病阶段肾指数之间的相关性。研究纳入了 101 例短期 T2DM 患者和 28 例对照组。收集患者的尿液,检测中性粒细胞明胶酶相关脂质运载蛋白(NGAL)、N-乙酰-β-D:-氨基葡萄糖苷酶(NAG)和肾损伤分子 1(KIM-1)等肾小管标志物,同时检测尿白蛋白排泄率。通过 Macisaac 公式估算肾小球滤过率(GFR)。根据尿白蛋白/肌酐比值(UACR),将患者进一步分为三组:正常白蛋白尿组、微量白蛋白尿组和大量白蛋白尿组。比较不同糖尿病组之间的肾小管标志物,并分析其与肾指数[UACR 和估算肾小球滤过率(eGFR)]的相关性。与对照组相比,T2DM 患者的尿 NGAL[中位数(IQR)][83.6(41.4-138.7)μg/gcr 比 32.9(26.1-64.5)μg/gcr]、NAG[13.5(8.7-17.9)U/gcr 比 7.6(6.5-13.0)U/gcr]和 KIM-1[120.0(98.4-139.9)ng/gcr 比 103.1(86.8-106.2)ng/gcr]均显著升高。所有患者中,尿 NGAL 与 UACR 的正相关性均强于 NAG(R=0.556 比 0.305,均 P<0.05)。此外,只有尿 NGAL 与 eGFR 呈负相关(R=-0.215,P<0.05)。然而,尿 KIM-1在三组 T2DM 患者之间无显著差异,且与 UACR 或 eGFR 均无相关性。随着 UACR 从正常白蛋白尿组增加到最后一个大量白蛋白尿组,所有标志物均增加。然而,只有 NGAL 的浓度在三组糖尿病患者之间存在统计学差异。肾小管标志物与肾指数之间的相关性在三组 T2DM 患者之间存在显著差异。总之,这些结果表明短期 T2DM 患者中肾小管损伤很常见。尿 NGAL 可能是监测短期 T2DM 患者肾损害的一种有前途的早期标志物。

相似文献

1
Urinary tubular biomarkers in short-term type 2 diabetes mellitus patients: a cross-sectional study.短期 2 型糖尿病患者的尿肾小管标志物:一项横断面研究。
Endocrine. 2012 Feb;41(1):82-8. doi: 10.1007/s12020-011-9509-7. Epub 2011 Jul 21.
2
Changes of the tubular markers in type 2 diabetes mellitus with glomerular hyperfiltration.2 型糖尿病伴肾小球高滤过患者管状标记物的变化。
Diabetes Res Clin Pract. 2012 Jan;95(1):105-9. doi: 10.1016/j.diabres.2011.09.031. Epub 2011 Oct 20.
3
Clinical outcome of renal tubular damage in chronic heart failure.慢性心力衰竭患者肾小管损伤的临床转归。
Eur Heart J. 2011 Nov;32(21):2705-12. doi: 10.1093/eurheartj/ehr190. Epub 2011 Jun 11.
4
Nonalbuminuric proteinuria as a biomarker for tubular damage in early development of nephropathy with type 2 diabetic patients.非白蛋白尿性蛋白尿作为 2 型糖尿病肾病早期小管损伤的生物标志物。
Diabetes Metab Res Rev. 2014 Nov;30(8):736-41. doi: 10.1002/dmrr.2546.
5
Clinical implication of urinary tubular markers in the early stage of nephropathy with type 2 diabetic patients.尿小管标记物在 2 型糖尿病肾病早期的临床意义。
Diabetes Res Clin Pract. 2012 Aug;97(2):251-7. doi: 10.1016/j.diabres.2012.02.019. Epub 2012 Mar 21.
6
Glomerular and tubular damage markers are elevated in patients with diabetes.肾小球和肾小管损伤标志物在糖尿病患者中升高。
Diabetes Care. 2011 Apr;34(4):975-81. doi: 10.2337/dc10-1545. Epub 2011 Feb 9.
7
Association of urinary KIM-1, L-FABP, NAG and NGAL with incident end-stage renal disease and mortality in American Indians with type 2 diabetes mellitus.尿KIM-1、L-FABP、NAG和NGAL与美国印第安2型糖尿病患者发生终末期肾病及死亡率的相关性
Diabetologia. 2015 Jan;58(1):188-98. doi: 10.1007/s00125-014-3389-3. Epub 2014 Oct 15.
8
Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM1) in patients with diabetic nephropathy: a cross-sectional study and the effects of lisinopril.中性粒细胞明胶酶相关脂质运载蛋白 (NGAL) 和肾损伤分子 1 (KIM1) 在糖尿病肾病患者中的作用:一项横断面研究及赖诺普利的影响。
Diabet Med. 2010 Oct;27(10):1144-50. doi: 10.1111/j.1464-5491.2010.03083.x.
9
Tubular markers do not predict the decline in glomerular filtration rate in type 1 diabetic patients with overt nephropathy.管状标记物不能预测显性肾病 1 型糖尿病患者肾小球滤过率的下降。
Kidney Int. 2011 May;79(10):1113-8. doi: 10.1038/ki.2010.554. Epub 2011 Jan 26.
10
Associations of urinary levels of kidney injury molecule 1 (KIM-1) and neutrophil gelatinase-associated lipocalin (NGAL) with kidney function decline in the Multi-Ethnic Study of Atherosclerosis (MESA).尿肾损伤分子 1(KIM-1)和中性粒细胞明胶酶相关脂质运载蛋白(NGAL)水平与动脉粥样硬化多民族研究(MESA)中肾功能下降的关系。
Am J Kidney Dis. 2012 Dec;60(6):904-11. doi: 10.1053/j.ajkd.2012.05.014. Epub 2012 Jun 30.

引用本文的文献

1
Changes in Urinary NGAL, FN, and LN Excretion in Type 2 Diabetic Patients Following Anti-Diabetic Therapy with Metformin.2型糖尿病患者接受二甲双胍抗糖尿病治疗后尿中性粒细胞明胶酶相关脂质运载蛋白、纤连蛋白和层粘连蛋白排泄量的变化
J Clin Med. 2025 Feb 8;14(4):1088. doi: 10.3390/jcm14041088.
2
Diagnostic value of α1-MG and URBP in early diabetic renal impairment.α1-微球蛋白和尿视黄醇结合蛋白在早期糖尿病肾损伤中的诊断价值
Front Physiol. 2023 Oct 19;14:1173982. doi: 10.3389/fphys.2023.1173982. eCollection 2023.
3
Evaluation of urinary haptoglobin level as a biomarker of diabetic nephropathy in children with type 1 diabetes.

本文引用的文献

1
Tubular markers do not predict the decline in glomerular filtration rate in type 1 diabetic patients with overt nephropathy.管状标记物不能预测显性肾病 1 型糖尿病患者肾小球滤过率的下降。
Kidney Int. 2011 May;79(10):1113-8. doi: 10.1038/ki.2010.554. Epub 2011 Jan 26.
2
Regression of microalbuminuria in type 1 diabetes is associated with lower levels of urinary tubular injury biomarkers, kidney injury molecule-1, and N-acetyl-β-D-glucosaminidase.1 型糖尿病患者微量白蛋白尿的消退与尿肾小管损伤生物标志物、肾损伤分子-1 和 N-乙酰-β-D-氨基葡萄糖苷酶的水平降低有关。
Kidney Int. 2011 Feb;79(4):464-70. doi: 10.1038/ki.2010.404. Epub 2010 Oct 27.
3
评估尿触珠蛋白水平作为 1 型糖尿病儿童糖尿病肾病的生物标志物。
Pediatr Nephrol. 2023 Nov;38(11):3693-3698. doi: 10.1007/s00467-023-06012-x. Epub 2023 May 18.
4
Molecular Pathways of Diabetic Kidney Disease Inferred from Proteomics.从蛋白质组学推断糖尿病肾病的分子途径
Diabetes Metab Syndr Obes. 2023 Jan 12;16:117-128. doi: 10.2147/DMSO.S392888. eCollection 2023.
5
Urinary RBP as an Independent Predictor of Renal Outcome in Diabetic Nephropathy.尿视黄醇结合蛋白作为糖尿病肾病肾脏结局的独立预测因子。
Dis Markers. 2022 Oct 17;2022:9687868. doi: 10.1155/2022/9687868. eCollection 2022.
6
Up-Date on Diabetic Nephropathy.糖尿病肾病的最新进展
Life (Basel). 2022 Aug 8;12(8):1202. doi: 10.3390/life12081202.
7
Prediction of the Short-Term Risk of New-Onset Renal Dysfunction in Patients with Type 2 Diabetes: A Longitudinal Observational Study.预测 2 型糖尿病患者新发肾功能障碍的短期风险:一项纵向观察研究。
J Immunol Res. 2022 Apr 20;2022:6289261. doi: 10.1155/2022/6289261. eCollection 2022.
8
Advances in Optical Sensors of -Acetyl-β-d-hexosaminidase (-Acetyl-β-d-glucosaminidase).β-己糖苷酶(β-葡糖苷酶)光学传感器的研究进展。
Bioconjug Chem. 2022 Apr 20;33(4):544-554. doi: 10.1021/acs.bioconjchem.2c00057. Epub 2022 Mar 18.
9
Urinary Extracellular Vesicles as a Source of NGAL for Diabetic Kidney Disease Evaluation in Children and Adolescents With Type 1 Diabetes Mellitus.尿细胞外囊泡作为 NGAL 的来源用于评估儿童和青少年 1 型糖尿病患者的糖尿病肾脏疾病。
Front Endocrinol (Lausanne). 2022 Jan 3;12:654269. doi: 10.3389/fendo.2021.654269. eCollection 2021.
10
Current Challenges and Future Perspectives of Renal Tubular Dysfunction in Diabetic Kidney Disease.糖尿病肾病中肾小管功能障碍的当前挑战和未来展望。
Front Endocrinol (Lausanne). 2021 Jun 10;12:661185. doi: 10.3389/fendo.2021.661185. eCollection 2021.
Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM1) in patients with diabetic nephropathy: a cross-sectional study and the effects of lisinopril.
中性粒细胞明胶酶相关脂质运载蛋白 (NGAL) 和肾损伤分子 1 (KIM1) 在糖尿病肾病患者中的作用:一项横断面研究及赖诺普利的影响。
Diabet Med. 2010 Oct;27(10):1144-50. doi: 10.1111/j.1464-5491.2010.03083.x.
4
Tubular damage in chronic systolic heart failure is associated with reduced survival independent of glomerular filtration rate.慢性收缩性心力衰竭中的管状损伤与肾小球滤过率降低无关,与存活率降低有关。
Heart. 2010 Aug;96(16):1297-302. doi: 10.1136/hrt.2010.194878.
5
Urinary biomarkers trefoil factor 3 and albumin enable early detection of kidney tubular injury.尿生物标志物三叶因子 3 和白蛋白可早期检测肾管状损伤。
Nat Biotechnol. 2010 May;28(5):470-7. doi: 10.1038/nbt.1624.
6
Effect of thiazolidinediones on albuminuria and proteinuria in diabetes: a meta-analysis.噻唑烷二酮类药物对糖尿病患者蛋白尿和白蛋白尿的影响:一项荟萃分析。
Am J Kidney Dis. 2010 May;55(5):835-47. doi: 10.1053/j.ajkd.2009.11.013. Epub 2010 Jan 29.
7
Kidney injury molecule-1 in renal disease.肾损伤分子-1 与肾脏疾病。
J Pathol. 2010 Jan;220(1):7-16. doi: 10.1002/path.2642.
8
Urinary L-FABP and anaemia: distinct roles of urinary markers in type 2 diabetes.尿 L-FABP 与贫血:尿标志物在 2 型糖尿病中的不同作用。
Eur J Clin Invest. 2010 Feb;40(2):95-102. doi: 10.1111/j.1365-2362.2009.02220.x. Epub 2009 Nov 11.
9
Integrating albuminuria and GFR in the assessment of diabetic nephropathy.在糖尿病肾病评估中整合蛋白尿和肾小球滤过率
Nat Rev Nephrol. 2009 Jul;5(7):397-406. doi: 10.1038/nrneph.2009.91.
10
Tubular and glomerular injury in diabetes and the impact of ACE inhibition.糖尿病中的肾小管和肾小球损伤以及血管紧张素转换酶抑制的影响
Diabetes Care. 2009 Sep;32(9):1684-8. doi: 10.2337/dc09-0429. Epub 2009 Jun 5.